ChemicalBook >> CAS DataBase List >>WDR5-IN-7

WDR5-IN-7

CAS No.
3032761-31-9
Chemical Name:
WDR5-IN-7
Synonyms
WDR5-IN-7;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-7-(1H-imidazol-1-ylmethyl)-9-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-4-[(5S)-5,6,7,8-tetrahydro-3-methoxy-5-quinolinyl]-
CBNumber:
CB614296338
Molecular Formula:
C28H27F3N6O3
Molecular Weight:
552.55
MDL Number:
MOL File:
3032761-31-9.mol
Last updated:2025-08-23 08:01:07

WDR5-IN-7 Properties

Boiling point 776.235±60.00 °C(Press: 760.00 Torr)(predicted)
Density 1.452±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

WDR5-IN-7 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0911025 WDR5-IN-7 98.10% 3032761-31-9 5mg $1733 2026-06-04 Buy
ChemScene CS-0911025 WDR5-IN-7 98.10% 3032761-31-9 10mg $3033 2026-06-04 Buy
ChemScene CS-0911025 WDR5-IN-7 98.10% 3032761-31-9 25mg $5698 2026-06-04 Buy
ChemScene CS-0911025 WDR5-IN-7 98.10% 3032761-31-9 50mg $8547 2026-06-04 Buy
Arctom HY-157332 WDR5-IN-7 98.10% 3032761-31-9 5mg $1520 2026-05-26 Buy
Product number Packaging Price Buy
CS-0911025 5mg $1733 Buy
CS-0911025 10mg $3033 Buy
CS-0911025 25mg $5698 Buy
CS-0911025 50mg $8547 Buy
HY-157332 5mg $1520 Buy

WDR5-IN-7 Chemical Properties, Uses, Production

Uses

WDR5-IN-7 (Compound 22) is an orally bioavailable benzoxazepinone-based WD repeat domain 5 (WDR5) inhibitor. WDR5-IN-7 can be used for the research of anti-cancer[1].

References

[1] Teuscher KB, et al. Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors. J Med Chem. 2023 Dec 12. DOI:10.1021/acs.jmedchem.3c01529

WDR5-IN-7 Preparation Products And Raw materials

Raw materials

Preparation Products

WDR5-IN-7 Suppliers

Global Suppliers ( 1)
Supplier Tel Email Country ProdList Advantage
TargetMol 400-821-0310 15002144251 xuexiang.shao@tsbiochem.com China 29128 58
Supplier Advantage
TargetMol 58
WDR5-IN-7 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-7-(1H-imidazol-1-ylmethyl)-9-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-4-[(5S)-5,6,7,8-tetrahydro-3-methoxy-5-quinolinyl]- 3032761-31-9